Uncategorized
Multiple Surgeons to Present Clinical Data Regarding Glaukos Glaucoma Devices at 2016 European Society of Cataract and Refractive Surgeons Congress
COPENHAGEN, Denmark--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, announced today that clinical data regarding its products will be presented in 12 Key Opinion Leader (KOL) podium and poster presentations at the annual Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) in Copenhagen, Den
